Additionally, we repeated all the above-mentioned experiments in GIST-T1 cells with SMYD2 silencing and the results obtained were consistent with those upon treatment with SMYD2 inhibitors (Fig. S4-A-G). Here, SMYD2 is linked to gastrointestinal stromal tumor.